Transgene
Tracked across 1 events · 6 articles · First seen Apr 13, 2026 · Last active May 28, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Transgene announced the completion of patient randomization in the Phase 2 part of its Phase 1/2 clinical trial for TG4050, a significant milestone for the company's individualized neoantigen therapeutic vaccine platform.
Apr 13, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Transgene live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard